Restart Life Sciences Corp. (NMLSF) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Vancouver, BC, 캐나다. 현재 CEO는 Steve Loutskou.
NMLSF 을(를) 보유 IPO 날짜 2008-06-27, 에 상장 Other OTC, 시가총액 $2.37M.
Restart Life Sciences Corp. is a biotechnology company, which engages in the research and development of psilocybin. It offers therapy and diagnostics for neuroinflammatory disorders. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
